Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Initial clinical data for CLN-978 in SLE and RA confirmed for Q2 2026; repeat dosing data in RA confirmed for Q3 2026Zipalertinib rolling NDA ...

Repligen Corporation (RGEN) Presents at Leerink Global Healthcare Conference 2026 Transcript

Leerink Global Healthcare Conference 2026 March 10, 2026 11:20 AM EDTCompany ParticipantsJason Garland - CFO & ...

BioNTech Announces Fourth Quarter and Full Year 2025 Financial Results and Corporate Update

BioNTech on track for a catalyst-rich year with six late-stage data readouts expected across immunomodulators, antibody-drug conjugates and mRNA ...

Incyte Corporation (INCY) Presents at Leerink Global Healthcare Conference 2026 Transcript

Leerink Global Healthcare Conference 2026 March 10, 2026 9:20 AM EDTCompany ParticipantsPablo Cagnoni - President and Head ...

BioNTech SE: BioNTech Announces Fourth Quarter and Full Year 2025 Financial Results and Corporate Update

BioNTech on track for a catalyst-rich year with six late-stage data readouts expected across immunomodulators, antibody-drug conjugates and mRNA cancer immunotherapies Increased focus on PD-L11/VEGF-A ...
AZoSensors on MSN

Review: Adaptive Microscopy Could Make Biological Imaging More Precise

This review outlines the potential of smart microscopy to transform biological imaging through adaptive systems that optimize data collection and image quality.